Rapid and Continuing Improvements in Nasal Symptoms with Dupilumab in Patients with Severe CRSwNP

PURPOSE: In the phase 3 SINUS-24 (NCT02912468) and SINUS-52 (NCT02898454) studies in adults with severe chronic rhinosinusitis with nasal polyps (CRSwNP), dupilumab significantly improved the co-primary endpoints of change from baseline to Week 24 in nasal polyp score (NPS) and nasal congestion/obst...

Descripción completa

Detalles Bibliográficos
Autores principales: Bachert, Claus, Khan, Asif H, Hopkins, Claire, Blaiss, Michael S, Soler, Zachary M, Nash, Scott, Siddiqui, Shahid, Praestgaard, Amy, Deniz, Yamo, Rowe, Paul J, Jacob-Nara, Juby A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081188/
https://www.ncbi.nlm.nih.gov/pubmed/35548056
http://dx.doi.org/10.2147/JAA.S355391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081188/
https://www.ncbi.nlm.nih.gov/pubmed/35548056
http://dx.doi.org/10.2147/JAA.S355391

Ejemplares similares